Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of a potassium-specific adsorbent for direct hemoperfusion

C Terai1, S Shimizu, S Matsushima

  • 1Department of Traumatology and Emergency Medicine, National Defense Medical College, Saitama, Japan.

Artificial Organs
|November 1, 1996
PubMed
Summary

Direct hemoperfusion using a novel resin mixture effectively lowers high potassium levels in dogs. This method shows promise for treating acute hyperkalemia without causing significant electrolyte imbalances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy.

Modern rheumatology·2014
Same author

Guillain-Barré syndrome accompanied by central nervous system lupus in a patient with juvenile rheumatoid arthritis.

Modern rheumatology·2014
Same author

Antiphospholipid syndrome with complete abdominal aorta occlusion and chondritis.

Modern rheumatology·2014
Same author

Immune recovery after autologous PBSC transplantation without in vitro graft manipulation for refractory systemic lupus erythematosus.

Bone marrow transplantation·2011
Same author

First measurement of the neutron beta asymmetry with ultracold neutrons.

Physical review letters·2009
Same author

Association of a polymorphism in the monocyte chemoattractant protein-1/CCL2 gene and lupus nephritis in systemic lupus erythematosus patients.

Clinical and experimental rheumatology·2008

Area of Science:

  • Nephrology
  • Cardiovascular Science
  • Biomaterials

Background:

  • Direct hemoperfusion (DHP) can lower serum potassium but causes electrolyte abnormalities.
  • Existing methods for hyperkalemia management have limitations.

Purpose of the Study:

  • To develop and evaluate a novel resin mixture for DHP to safely remove potassium from blood.
  • To assess the efficacy and safety of this DHP method in a preclinical model.

Main Methods:

  • In vitro studies were conducted to optimize a sodium/calcium/magnesium exchange resin mixture.
  • Direct hemoperfusion (DHP) using the optimized resin mixture was performed on anephric dogs for 2 hours.
  • Plasma electrolyte levels, albumin, total protein, cholesterol, platelet count, and free hemoglobin were monitored.

Related Experiment Videos

Main Results:

  • The resin mixture (48% sodium, 48% calcium, 4% magnesium) effectively reduced elevated plasma potassium levels in dogs (6.7 +/- 1.1 to 3.5 +/- 0.6 mEq/L).
  • No significant changes were observed in sodium, calcium, magnesium, albumin, total protein, or cholesterol levels.
  • Platelet losses and plasma free hemoglobin changes were comparable to activated charcoal hemoperfusion.

Conclusions:

  • This novel resin hemoperfusion effectively lowers potassium levels without causing significant electrolyte disturbances.
  • The findings suggest that this DHP approach may be a viable treatment option for patients suffering from acute hyperkalemia.